Search

Your search keyword '"E, Loyd"' showing total 376 results

Search Constraints

Start Over You searched for: Author "E, Loyd" Remove constraint Author: "E, Loyd"
376 results on '"E, Loyd"'

Search Results

1. Erratum to: Evidence of Mass Ordering of Charm and Bottom Quark Energy Loss in Au+Au Collisions at RHIC

2. Evidence of Mass Ordering of Charm and Bottom Quark Energy Loss in Au+Au Collisions at RHIC

3. Beam energy dependence of the linear and mode-coupled flow harmonics in Au+Au collisions

4. Search for the chiral magnetic effect in Au+Au collisions at sNN=27 GeV with the STAR forward event plane detectors

5. Measurement of HΛ4 and HeΛ4 binding energy in Au+Au collisions at sNN = 3 GeV

6. Probing strangeness canonical ensemble with K−, ϕ(1020) and Ξ− production in Au+Au collisions at sNN=3 GeV

7. Light nuclei collectivity from sNN=3 GeV Au+Au collisions at RHIC

8. Disappearance of partonic collectivity in sNN=3GeV Au+Au collisions at RHIC

9. Measurement of cold nuclear matter effects for inclusive J/ψ in p+Au collisions at sNN=200 GeV

10. The Genetic Landscape of Familial Pulmonary Fibrosis

11. Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort

12. Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension

13. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

15. A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis

16. Postdeployment Respiratory Syndrome in Soldiers With Chronic Exertional Dyspnea

17. The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis

18. CD4+CTLs in Fibrosing Mediastinitis Linked to Histoplasma capsulatum

19. Evidence for Nonlinear Gluon Effects in QCD and Their Mass Number Dependence at STAR

20. Gene expression profiling: can we identify the right target genes?

21. Measurements of Proton High-Order Cumulants in sqrt[s_{NN}]=3 GeV Au+Au Collisions and Implications for the QCD Critical Point

22. Measurements of _{Λ}^{3}H and _{Λ}^{4}H Lifetimes and Yields in Au+Au Collisions in the High Baryon Density Region

23. Invariant jet mass measurements in pp collisions at s=200 GeV at RHIC

24. Erector Spinae Plane Catheters for Analgesia for Cytoreduction Surgery With Hyperthermic Intraperitoneal Chemotherapy: A Case Series

25. Cumulants and correlation functions of net-proton, proton, and antiproton multiplicity distributions in Au+Au collisions at energies available at the BNL Relativistic Heavy Ion Collider

26. Search for the Chiral Magnetic Effect via Charge-Dependent Azimuthal Correlations Relative to Spectator and Participant Planes in Au+Au Collisions at sqrt[s_{NN}]=200 GeV

27. Azimuthal anisotropy measurements of strange and multistrange hadrons in U+U collisions at sNN=193 GeV at the BNL Relativistic Heavy Ion Collider

28. Case series of pediatric mediastinal granuloma related to histoplasmosis

29. Measurement of the Sixth-Order Cumulant of Net-Proton Multiplicity Distributions in Au+Au Collisions at sqrt[s_{NN}]=27, 54.4, and 200 GeV at RHIC

30. Longitudinal double-spin asymmetry for inclusive jet and dijet production in polarized proton collisions at s=200 GeV

31. Flow and interferometry results from Au+Au collisions at sNN=4.5 GeV

32. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease.

33. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis

34. Among Individuals At-Risk, Pre-Clinical Pulmonary Fibrosis Occurs Commonly and Is Progressive

35. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension (PH) Associated with Fibrotic Interstitial Lung Disease (fILD) on Long Term Oxygen Therapy

36. FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension

37. Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement

38. OPEN-LABEL DOSE-ESCALATION DATA FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF PULSED, INHALED NITRIC OXIDE (INO) IN SUBJECTS AT RISK OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY FIBROSIS (PH-PF) ON LONG TERM OXYGEN THERAPY

39. Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.

40. Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families

41. A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal

42. Genetics of Pulmonary Arterial Hypertension

43. Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis

44. Pulmonary arterial hypertension: Specialists’ knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA

45. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease

46. Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case–control study

47. List of Contributors

48. MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis

49. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

50. A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) at a Dose of 30 mcg/kg-IBW/hr (iNO 30) in Subjects at Risk of Pulmonary Hypertension Associated with Pulmonary Fibrosis (PH-PF) on Long Term Oxygen Therapy

Catalog

Books, media, physical & digital resources